Question 1

How should we select a small set of RTBs from a large set of credible options?

Accepted Answer

To choose a few powerful "reasons to believe" (RTBs) from a long list of credible points, focus on the ones that most strongly reinforce your core promise and resonate with your audience. Start by filtering out any RTBs that are redundant or tangential — you want each selected reason to cover distinct ground in supporting the product's main benefit. It often helps to test or gather quick feedback on the large set of RTBs (through a survey or stakeholder input) to identify which points actually increase a customer's interest or trust the most. Then select a small number (usually two to three) that together provide a compelling, non-overlapping proof set. By spotlighting only the most convincing and relevant reasons, you avoid diluting the message and give your audience a clear, memorable case for believing in the offering.

Question 2

Can AI tools improve forecasting for new drug launches?

Accepted Answer

Yes, AI tools can make new drug launch forecasts more sophisticated by analyzing complex patterns across many data sources, but they complement rather than completely replace traditional forecasting. Forecasting a novel drug's uptake is tricky, especially with limited analogs. AI and machine learning can help by processing vast amounts of data — beyond what an analyst could handle — such as patient demographics, physician prescribing behaviors, formulary and insurance data, and even social media or key opinion leader sentiment. For example, an AI model might detect that a drug with a certain efficacy profile and marketing mix follows a launch trajectory similar to past drugs in related categories, adjusting predictions as real-world prescription data starts coming in. This often yields a more nuanced forecast that updates in near real time. However, because every new drug has unique aspects (a novel mechanism, different competition, regulatory nuances), AI predictions need expert oversight. Companies typically use AI-driven forecasts alongside traditional analog-based methods and expert input. The AI improves accuracy by uncovering patterns and early indicators, while human experts ensure the predictions make sense given any one-of-a-kind factors.

Question 3

What ethical concerns arise when forecasting consumer behavior with AI?

Accepted Answer

Using AI to predict consumer behavior raises several ethical flags, mainly around bias, privacy, and accountability. One concern is that the algorithms may learn from historical data that contain biases - for example, disproportionately under-predicting interest from certain demographic groups - thus reinforcing unfair treatment_x000D_. Privacy is another issue: forecasting models often ingest large amounts of personal consumer data, so if that data was collected without clear consent or isn't handled securely, it violates trust. There's also the opacity problem: AI forecasts can be a "black box," making it hard to explain to stakeholders (or consumers) why a certain prediction was made, which complicates accountability. Finally, there's the risk of self-fulfilling prophecies or manipulation: if companies act on AI predictions in heavy-handed ways, they might inadvertently limit consumer choice or target people in ways that feel invasive. In short, fairness, transparency, and respecting consumer data rights are key ethical considerations when using AI for behavior forecasting.

Question 4

What ethical considerations apply when tracking the same participants over time?

Accepted Answer

When tracking the same participants over time, researchers need to uphold strict ethical standards around consent, privacy, and participant well-being. First, informed consent must be ongoing: participants should know they're part of a longitudinal study and be reminded that their continued participation is voluntary (with the right to withdraw at any point). Privacy is crucial as you accumulate data on individuals — personal information must be securely stored, and any reporting should anonymize their identities to prevent someone from being recognized in the findings. Researchers also have to minimize participant burden and potential discomfort; checking in repeatedly can become intrusive, so it's important to space out contacts reasonably and only collect necessary information. By being transparent, respecting boundaries, and protecting data confidentiality throughout the study, you address the key ethical considerations of long-term participant tracking.

Question 5

How do neuro signals forecast long-term memory and repeat purchase?

Accepted Answer

Certain neuro signals measured during consumer testing--like indicators of strong memory encoding or emotional engagement--have been linked to a higher likelihood of long-term brand recall and even repeat purchasing behavior. In practice, neuromarketing researchers might use EEG or other biometrics to see if an ad or experience is triggering brain responses (for example, activity patterns associated with memory formation) that indicate information is "sticking." If a stimulus creates a spike in those memory-encoding signals, it suggests consumers are more likely to remember the product or message later on. That sustained memory can translate to behavior: when it comes time to buy again, the consumer recalls the brand positively and is more inclined to choose it. In essence, by revealing which marketing content embeds itself in memory, these neuro metrics help predict which messages will drive repeat purchase and loyalty down the line.

The Wagner Group, Inc.

What is The Wagner Group, Inc.?

Services and Expertise

Market Research FAQs with Expert Insights

How should we select a small set of RTBs from a large set of credible options?

Can AI tools improve forecasting for new drug launches?

What ethical concerns arise when forecasting consumer behavior with AI?

What ethical considerations apply when tracking the same participants over time?

How do neuro signals forecast long-term memory and repeat purchase?